Credevo

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Credevo, Health/Medical/ Pharmaceuticals, Singapore.

A global Clinical Trial Organization (CTO) providing comprehensive clinical trial services for pharmaceuticals, biologics, medical devices and healthcare products Credevo provides strategic support for healthcare products including;

- Drugs

- Biologics

- Health Supplements (Nutraceuticals)

- IVD and medical devices

- Cosmetics

In areas of

- Regulatory

- Clinical Development

- Business Development Support

- Licensing (out-/in-)

- Feasibility

17/11/2025

💡 Want Faster Site Activation? Start Engaging Early

Strong site engagement can make or break a clinical trial. Early planning and consistent collaboration lead to faster activation and better data.

📍 When to Start:
✅ Begin at the pre-feasibility stage
✅ Engage sites 6–12 months before study start
✅ Align expectations early to avoid delays

📍 How to Use It Effectively:
✅ Keep clear, regular communication
✅ Provide focused GCP and eCRF/EDC training
✅ Use tech for real-time monitoring
✅ Review performance and share feedback

🚀 Results: Faster activation, better recruitment, higher data quality, stronger site partnerships.

Read more 👉 https://tinyurl.com/k65r436w

14/11/2025

🩺 Is Your Medical Device Ready for Taiwan FDA Approval?

Taiwan’s MedTech market is growing fast. Clear understanding of TFDA rules is key for smooth entry and compliance.

📌 Essentials
✅ All devices must register with TFDA
✅ Foreign firms need a Local Authorized Representative (LAR)
✅ Devices are risk-classified (I–III), including IVDs
✅ ISO 13485 (QSD) required for most devices
✅ Timelines: Class I ~1–2 months | Class III up to 9–14 months
✅ Licences valid 5 years | QSD 3 years

Strong local partnerships and proactive planning drive faster, safer approvals.

Discover more: https://tinyurl.com/3pzp4pmx

13/11/2025

🔬 Mastering Regulatory Life Cycle Management in Pharma

Effective RLCM ensures product safety, compliance, and market continuity from development to post-marketing.

💡 Key points
✅ Maintain updated dossiers and adapt to local regulations
✅ Manage complex global portfolios and evolving rules
✅ Prioritise data integrity and cross-functional alignment

⚙️ Best practices
🔹 Empower skilled regulatory teams
🔹 Use tech for data and document control
🔹 Strengthen risk management and training

🚀 Strong RLCM keeps pharma organisations compliant, agile, and trusted.

For more insights 👉: https://tinyurl.com/54wfs2w4

12/11/2025

Inside APAC’s Booming Generic Drug Market 🚀

The APAC generic drug market is growing rapidly - projected to reach USD 132.4 billion by 2029 (CAGR ≈ 8.3%).
Key drivers include manufacturing strength in India and China, expanding healthcare access, and government policies promoting affordability.

Yet, growth comes with complexity.
Regulatory agencies demand robust data on quality, safety, and bioequivalence, with some requiring local clinical trials before approval. Ensuring compliance while maintaining cost efficiency is now a defining challenge for manufacturers.

📍 Discover more about the regulatory and market dynamics shaping generics in APAC: https://tinyurl.com/4ff3j27z

11/11/2025

Unlocking Success in Pancreatitis Clinical Trials 🌍🧪

Incidence: 70-80 new cases per 100,000 in the U.S., 5-35 globally

Main Causes: Gallstones and heavy alcohol use account for 80% of acute cases

Trial Landscape: 225 clinical trials globally, major studies in the U.S., China, India, Spain

Feasibility: Assessments in South Asia, U.S., U.K., and Europe help sponsors plan trials efficiently and anticipate challenges before starting a Phase III study

Feasibility assessments are crucial in complex conditions like pancreatitis, guiding site selection, recruitment strategies, and trial design to improve success rates.

👉 Discover more: https://tinyurl.com/nanbc3xv

10/11/2025

Navigating Clinical Trial Logistics in Africa with IOR Services 🌍📦

• Complex infrastructure and import/export rules create logistical challenges ⚠️
• Importer of Record (IOR) services handle customs clearance and regulatory compliance ✅
• Local partnerships help streamline trials, reduce delays, and maintain material integrity ⏱️

👉 Explore the full article: https://tinyurl.com/3hm6ed6e

07/11/2025

Driving Smarter Clinical Trials in North America ⚙️💡

AI, connected devices, and decentralised trial models are transforming clinical operations. Trials are faster, more efficient, and designed around patient needs.

Regulators like the FDA and Health Canada are guiding this innovation. Risk-based monitoring is helping teams maintain compliance while improving efficiency and data integrity.

👉 Read more: https://tinyurl.com/4v3c2c8x

06/11/2025

🌍 Did you know the orphan drug market could reach $450B by 2030? Here’s why global trials are key

Orphan drugs face unique challenges due to limited patient populations. Global trials help overcome these hurdles:

👩‍⚕️ Increased Patient Access: Reach patients across multiple countries

🧬 Genetic Diversity: Study disease across varied populations

📊 Larger Data Pool: Combine patients for robust analysis

⚖️ Regulatory Compliance: Align with multi-region standards

🌏 Global Market Access: Ensure availability worldwide

Global trials accelerate approvals and bring life-saving therapies to more patients.

🔗 Discover full insights: https://tinyurl.com/yckb2xmn

05/11/2025

💡 FSP Model + Thailand: A Winning Formula for Faster, Smarter Trials

Thailand’s rise as a clinical trial hub is powered by the FSP model, outsourcing key functions with sponsor control.

Why it works:
🎯 Dedicated functional teams for monitoring, regulatory, data

⏱ Flexible resource scaling based on trial needs

👩‍⚕️ Expert investigators, diverse patients

⚡ Streamlined regulatory approvals and digital submissions with the Thai FDA

🏥 Growing infrastructure beyond Bangkok

The FSP model speeds up trials with local expertise.

🔗 Find out more: https://tinyurl.com/4bhvse8m

04/11/2025

💡 Did You Know Early Site Engagement Can Make or Break Your Trial?

Engaging clinical trial sites early before finalising protocols significantly improves trial success:

⚕️ Aligning with Standard of Care (SOC): Understanding local treatment practices ensures protocols are feasible and ethically sound.

⚖️ Selecting Appropriate Comparator Arms: Early site input helps identify relevant and acceptable comparators, avoiding ethical concerns and enhancing patient acceptability.

📊 Gauge Site Interest and Capacity: Identify ready and motivated sites to boost recruitment efficiency.

Early engagement helps sponsors design more effective trials, prevent delays, and foster stronger site relationships.

🔗 Explore more to see how early site engagement drives trial success: https://tinyurl.com/ywewmcw5

03/11/2025

Thinking of expanding your clinical trials globally? Start with Australia. 🇦🇺

Here are 7 compelling reasons why Australia stands out:

✅ Fast regulatory approval through the CTN scheme
✅ Highly skilled medical and research workforce
✅ Strong ethics and regulatory oversight
✅ World-class infrastructure and research facilities
✅ Diverse and engaged participant pool
✅ Attractive R&D tax incentives
✅ No need for FDA IND to initiate trials

From streamlined approvals to globally accepted data, Australia offers efficiency without compromise.

💡 Learn more about how to get started with clinical trials in Australia: https://tinyurl.com/yvh57dvw

31/10/2025

⚡ Regulatory Incentives Driving Orphan Drug Development Across Asia

Countries across Asia are strengthening frameworks to accelerate rare disease therapies. Key updates include:

🇰🇷 South Korea – 👥 Simplified application procedures and broader eligibility for orphan drug designation.
🇮🇳 India – ⚡ NDCTR 2019 enables fast-track approvals, fee waivers, and conditional trial exemptions for orphan drugs.
🇨🇳 China – 🌏 Acceptance of overseas clinical data; defined review timelines of 3–6 months.
🇷🇺 Russia – 📄 Accelerated dossier review and acceptance of foreign clinical trial data meeting GCP/GLP standards.

These updates signal a regulatory shift towards faster and more globally aligned orphan drug development in Asia.

👉 Read more: https://tinyurl.com/yc4jp2ze

Address

Singapore

Website

https://credevo.com/

Alerts

Be the first to know and let us send you an email when Credevo posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Featured

The Prenatal Consultants
101 Irrawaddy Road, #15-05/06 Royal Square Medical Centre

Want your practice to be the top-listed Clinic in Singapore?